Institutional Ownership
Arcturus Therapeutics Hldgs
CUSIP 03969T109COMARCTQ1 2026
13D / 13G Filings
53
Schedule 13D/13G on record
Beneficial Filers
18
Distinct reporting persons
Largest Stake
17.6%
Max % of class reported
Institutional Holders
121
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
53 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Balyasny Asset Management L.P. | 13G/A | — | — | SEC |
| 2 | Feb 3, 2026 | Ark Investment Management LLC | 13G/A | 9.2% | 2.61M | SEC |
| 3 | Jan 8, 2026 | Federated Hermes, Inc. | 13G/A | 11.6% | 3.30M | SEC |
| 4 | Nov 14, 2025 | Balyasny Asset Management L.P. | 13G | 8.0% | 2.18M | SEC |
| 5 | Nov 13, 2025 | Amova Asset Management Americas, Inc. | 13G/A | 7.2% | 1.95M | SEC |
| 6 | Oct 27, 2025 | Sumitomo Mitsui Trust Group, Inc. | 13G/A | 7.2% | 1.95M | SEC |
| 7 | Jul 30, 2025 | Ark Investment Management LLC | 13G/A | 6.3% | 1.72M | SEC |
| 8 | Jul 29, 2025 | The Vanguard Group | 13G/A | 6.7% | 1.81M | SEC |
| 9 | May 12, 2025 | Nikko Asset Management Americas, Inc. | 13G/A | 7.1% | 1.93M | SEC |
| 10 | Apr 25, 2025 | Sumitomo Mitsui Trust Group, Inc. | 13G/A | 7.1% | 1.93M | SEC |
43 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Arcturus Therapeutics Hldgs.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Federated Hermes, Inc. | 3.30M | $25.50M |
| 2 | Ark Investment Management LLC | 2.77M | $21.38M |
| 3 | Blackrock, Inc. | 2.61M | $20.17M |
| 4 | Sumitomo Mitsui Trust Group, Inc. | 2.29M | $17.67M |
| 5 | Amova Asset Management Americas, Inc. | 2.29M | $17.65M |
| 6 | Two Sigma Investments, LP | 1.08M | $8.35M |
| 7 | Geode Capital Management, LLC | 660.9K | $5.10M |
| 8 | State Street Corp | 543.9K | $4.20M |
| 9 | Millennium Management LLC | 478.6K | $3.69M |
| 10 | Ubs Group AG | 458.3K | $3.54M |